stocktools
Dilution profile // every instrument, one screen, from SEC filings

Ping An Biomedical Co., Ltd. (PASW)

CIK 1897532 · all EDGAR filings →

Overall dilution risk
HIGHworst of 2 computed signals (cash need)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
MEDIUM$3.0M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
NOT COMPUTEDunder 3 years of share history on file
= share count now vs 3 years ago
Cash need
HIGH~2.2 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Fewer than two cover-page share counts on file, so there is no history to chart.

Cash runway

~2 months of cash left

critical · burning $225,725.5 / quarter

Full breakdown: cash runway tool

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Registrations and offerings

Registered offering capacity on live registrations: $3.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-1Feb 13, 2026$3.0M registeredfiling →
F-1Oct 4, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 1 registered.

EFFECTIVEFeb 26, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDFeb 13, 2026F-1 registration — capacity to sell shares, not a sale yetF-1 →
EXECUTEDJul 21, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
UPDATEJul 21, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →
MARKETINGJul 11, 2025Free-writing prospectus — offering being marketedFWP →
EFFECTIVEJun 30, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJun 26, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
REGISTEREDApr 14, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
REGISTEREDMar 25, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
MARKETINGMar 18, 2025Free-writing prospectus — offering being marketedFWP →
REGISTEREDMar 17, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
REGISTEREDJan 24, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full PASW workspace